143 results
Page 6 of 8
424B5
nmy9dbo7e 1jlaac73d
28 Oct 10
Prospectus supplement for primary offering
12:00am
424B5
u6l90a4ple6pq477w0uj
27 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
6hk5icedx2y8pxv
27 Oct 10
Results of Operations and Financial Condition
12:00am
424B5
490t6w 8jl5r
20 Sep 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
3zhx n2skf
13 Apr 10
Dynavax Raises $44 Million Through Public Offering
12:00am
8-K
EX-99.1
j9owj
17 Feb 10
Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVTM
12:00am
8-K
EX-99.1
28hcq
8 Feb 10
Other Events
12:00am
8-K
EX-99.1
0s6gtixpyx33qrv
10 Dec 09
Dynavax’s European Manufacturing Facility Approved for Commercial Production of
12:00am